Technical Analysis for ALPMY - Astellas Pharma Inc

Grade Last Price % Change Price Change
grade C 13.475 1.77% 0.2350
ALPMY closed up 1.77 percent on Friday, August 16, 2019, on 1.57 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical ALPMY trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup 1.77%
Cup with Handle Other 1.77%
Narrow Range Bar Range Contraction 1.77%
Stochastic Reached Oversold Weakness 1.77%
Inside Day Range Contraction 1.77%
Oversold Stochastic Weakness 1.77%
Cup with Handle Other 2.01%
Narrow Range Bar Range Contraction -0.04%

Older signals for ALPMY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceutical products worldwide. The company offers XTANDI and Eligard for the treatment of prostate cancer; Betanis/Myrbetriq/BETMIGA for overactive bladder (OAB) treatment; Vesicare forOAB treatment; Harnal/Omnic for functional symptoms associated with benign prostatic hyperplasia; VESOMNI for storage symptoms and voiding symptoms associated with benign prostatic hyperplasia; Prograf and Advagraf/Graceptor/ASTAGRAF XL/Prograf XL, animmunosuppressant; and Funguard/MYCAMINE, a candin-type antifungal agent. It also provides Celecox, an anti-inflammatory agent; Lipitor, a treatment for hypercholesterolemia; Micardis/Micombi/Micamlo, a treatment for hypertension; Symbicort for the treatment for adult bronchial asthma and chronic obstructive pulmonary disease; Bonoteo for the treatment for osteoporosis; Suglat for the treatment of type 2 diabetes; and Repatha for the treatment of hypercholesterolemia. In addition, it offers Lexiscan, a pharmacologic stress agent; Tarceva, a treatment for non-small cell lung cancer; CRESEMBA, a azole antifungal; and Dificlir, a novel treatment for CDI. Additionally, it is developing enzalutamide, gilteritinib, enfortumab vedotin, zolbetuximab, roxadustat, and fezolinetant for oncology indications. The company has a collaboration with Actinium Pharmaceuticals, Inc. to apply Actinium warhead enabling technology platform for generating Actinium radio-conjugates with various Astellas targeting agents. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan.
Chemistry Medicine Diabetes Hypertension Prostate Cancer Osteoporosis Chronic Obstructive Pulmonary Disease Organic Chemistry Non Small Cell Lung Cancer Mitsubishi Ufj Financial Group Benign Prostatic Hyperplasia Lactams Overactive Bladder Exports Pharmaceutical Products Hypercholesterolemia Hyperplasia Adult Bronchial Asthma Astellas Pharma Enzalutamide Tacrolimus Tamsulosin Treatment For Hypertension Treatment For Non Small Cell Lung Cancer Treatment For Osteoporosis Treatment Of Prostate Cancer
Is ALPMY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 17.99
52 Week Low 12.41
Average Volume 56,452
200-Day Moving Average 14.2833
50-Day Moving Average 13.9409
20-Day Moving Average 13.7801
10-Day Moving Average 13.5115
Average True Range 0.2798
ADX 13.18
+DI 26.8223
-DI 34.8572
Chandelier Exit (Long, 3 ATRs ) 13.7106
Chandelier Exit (Short, 3 ATRs ) 13.9194
Upper Bollinger Band 14.5199
Lower Bollinger Band 13.0403
Percent B (%b) 0.29
BandWidth 10.737223
MACD Line -0.1846
MACD Signal Line -0.1378
MACD Histogram -0.0468
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.8650
Resistance 3 (R3) 13.8300 13.6650 13.8000
Resistance 2 (R2) 13.6650 13.5657 13.6825 13.7783
Resistance 1 (R1) 13.5700 13.5043 13.6175 13.6050 13.7567
Pivot Point 13.4050 13.4050 13.4288 13.4225 13.4050
Support 1 (S1) 13.3100 13.3057 13.3575 13.3450 13.1933
Support 2 (S2) 13.1450 13.2443 13.1625 13.1717
Support 3 (S3) 13.0500 13.1450 13.1500
Support 4 (S4) 13.0850